Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis Group.
Rocamora V, Crespi L, Ferran M, Llamas-Velasco M, Del Alcázar E, Carrascosa JM, Beltran E, Urruticoechea-Arana A, Estebaranz JLL, Vidal D, Riera J, Rodríguez L, Armesto S, Fernández JM, Aparicio G, Pérez S, Porcar S, Montesinos E, Gallardo F. Rocamora V, et al. Among authors: aparicio g. Dermatol Ther. 2022 Nov;35(11):e15865. doi: 10.1111/dth.15865. Epub 2022 Oct 9. Dermatol Ther. 2022. PMID: 36175141
Effectiveness and safety of ustekinumab 90 mg in patients weighing 100 kg or less: a retrospective, observational, multicenter study.
Del Alcázar E, Ferran M, López-Ferrer A, Notario J, Vidal D, Riera J, Aparicio G, Gallardo F, Vilarrasa E, Alsina M, Puig L, Ferrándiz C, Carrascosa JM. Del Alcázar E, et al. Among authors: aparicio g. J Dermatolog Treat. 2020 May;31(3):222-226. doi: 10.1080/09546634.2019.1597245. Epub 2019 Apr 2. J Dermatolog Treat. 2020. PMID: 30883242
Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study.
Montes-Torres A, Aparicio G, Rivera R, Vilarrasa E, Marcellán M, Notario J, Soria C, Belinchón I, de la Cueva P, Ferrán M, Carrascosa JM, Gómez FJ, Salgado L, Velasco M, Descalzo MÁ, García-Doval I, Daudén E; ; the BIOBADADERM Study Group and Psoriasis Group of the AEDV. Montes-Torres A, et al. Among authors: aparicio g. J Dermatolog Treat. 2019 Aug;30(5):461-465. doi: 10.1080/09546634.2018.1535690. Epub 2018 Nov 28. J Dermatolog Treat. 2019. PMID: 30307344
Use of biological treatments in patients with hidradenitis suppurativa.
Martin-Ezquerra G, Masferrer E, Masferrer-Niubò M, Ferran M, Sánchez-Regaña M, Collgros H, Bordas X, Notario J, Alsina M, Gil I, Izquierdo N, Aparicio G, Mollet J, Garcia-Patos V, Pujol RM. Martin-Ezquerra G, et al. Among authors: aparicio g. J Eur Acad Dermatol Venereol. 2015 Jan;29(1):56-60. doi: 10.1111/jdv.12438. Epub 2014 Mar 13. J Eur Acad Dermatol Venereol. 2015. PMID: 24629001
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.
Mahil SK, Dand N, Mason KJ, Yiu ZZN, Tsakok T, Meynell F, Coker B, McAteer H, Moorhead L, Mackenzie T, Rossi MT, Rivera R, Mahe E, Carugno A, Magnano M, Rech G, Balogh EA, Feldman SR, De La Cruz C, Choon SE, Naldi L, Lambert J, Spuls P, Jullien D, Bachelez H, McMahon DE, Freeman EE, Gisondi P, Puig L, Warren RB, Di Meglio P, Langan SM, Capon F, Griffiths CEM, Barker JN, Smith CH; PsoProtect study group. Mahil SK, et al. J Allergy Clin Immunol. 2021 Jan;147(1):60-71. doi: 10.1016/j.jaci.2020.10.007. Epub 2020 Oct 16. J Allergy Clin Immunol. 2021. PMID: 33075408 Free PMC article. Clinical Trial.
A newborn with erythematous, desquamative plaques.
Bodet D, Bassas P, Bartralot R, Mollet J, Aparicio G, Heras C, Huguet P, Labrador M, García-Patos V. Bodet D, et al. Among authors: aparicio g. Pediatr Dermatol. 2008 Jan-Feb;25(1):97-8. doi: 10.1111/j.1525-1470.2007.00593.x. Pediatr Dermatol. 2008. PMID: 18304163 No abstract available.
78 results